Comments

Mereo BioPharma Group Stock Price, Quotes and Forecasts

Q: What sector and industry does Mereo BioPharma Group (MREO) operate in?

Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

MREONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$2.23

0.020.90%

Pre-Market: 7:31 PM EDT

Mereo BioPharma Group (MREO) Forecast

News Earnings Mereo BioPharma Group (MREO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Mereo BioPharma Group Stock Price, Quotes and Forecasts | NASDAQ:MREO | Benzinga

Explore Mereo BioPharma Group stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for MREO.

Open	-
Close	-
Volume / Avg.	0 / 1.27M
Day Range	- - -
52 Wk Range	2.11 - 5.02
Market Cap	$354.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	4.47%
Days to Cover	4.08

Recent News

This Roper Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential

Stocks priced under $10 present an attractive entry point into the market for investors seeking to maximize portfolio diversification and growth potential without a significant upfront capital outlay. These affordable

MarketBeat

This ServiceNow Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Dec 24

Jan

Mar

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / 1.27M
Day Range	- - -
52 Wk Range	2.11 - 5.02
Market Cap	$354.57M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	4.47%
Days to Cover	4.08

About Mereo Biopharma Group Plc

Sector

Health Care

Industry

Biotechnology

Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the ...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Mereo BioPharma Group (MREO) stock?

You can purchase shares of Mereo BioPharma Group (NASDAQ:MREO) through any online brokerage.

View our list of the best stock brokerages

Who are Mereo BioPharma Group (MREO) competitors?

Other companies in Mereo BioPharma Group’s space includes: Precigen (NASDAQ:PGEN), Upstream Bio (NASDAQ:UPB), Celcuity (NASDAQ:CELC), Immatics (NASDAQ:IMTX) and Sage Therapeutics (NASDAQ:SAGE).

What is the forecast, or price target, for Mereo BioPharma Group (MREO) stock?

Mereo BioPharma Group has a consensus price target of $7.25.

What is the current price for Mereo BioPharma Group (MREO)?

The stock price for Mereo BioPharma Group (NASDAQ: MREO) is $2.23 last updated April 3, 2025 at 7:31 PM EDT.

Does Mereo BioPharma Group (MREO) pay a dividend?

There are no upcoming dividends for Mereo BioPharma Group.

When is Mereo BioPharma Group (NASDAQ:MREO) reporting earnings?

Mereo BioPharma Group’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Is Mereo BioPharma Group (MREO) going to split?

There is no upcoming split for Mereo BioPharma Group.

What sector and industry does Mereo BioPharma Group (MREO) operate in?

Mereo BioPharma Group is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.